Verrica Pharmaceuticals Inc. Stockholders' Equity Note, Subscriptions Receivable
Verrica Pharmaceuticals Inc. (VRCA) had Stockholders' Equity Note, Subscriptions Receivable of $4.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-13.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquityNoteSubscriptionsReceivable · last filed 2024-05-13
- 2024-03-31: Stockholders' Equity Note, Subscriptions Receivable $4.00K.
- 2023-12-31: Stockholders' Equity Note, Subscriptions Receivable $0.00.
- 2020-09-30: Stockholders' Equity Note, Subscriptions Receivable $446.00K.
- 2019-12-31: Stockholders' Equity Note, Subscriptions Receivable $410.00K.
| Period end | Stockholders' Equity Note, Subscriptions Receivable |
|---|---|
| 2024-03-31 | $4.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $0.00 10-Q · filed 2024-05-13 |
| 2020-09-30 | $446.00K 10-Q · filed 2020-11-09 |
| 2019-12-31 | $410.00K 10-K · filed 2021-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |